Through its Digital Patient Workflow Solution (DPWS) collaboration, UCSF’s Center for Digital Health Innovation (CDHI) and WeHealth By Servier are looking for early stage companies developing digital therapeutics and clinical decision support solutions in the following five therapeutic areas:
— Cardiovascular diseases
— Neuropsychiatric diseases
— Immune-inflammatory diseases
Between April and June, CDHI and WeHealth will be accepting applications for the ultimate goal of establishing an agreement for funding and mentorship with one or two early stage companies. Our team will then conduct due diligence on companies who apply below, and qualifying candidates will be invited to present in September. The final selection of companies will occur in October.
— Seed funding to Series B companies only, preferably with no pre-existing biopharma funding
— Applying company to have a digital solution (either clinical decision support or digital therapeutic) that impacts the patient journey in the disease areas of oncology, cardiovascular, diabetes, neuropsychiatric or immune-inflammatory diseases
— The digital solution has the potential for global impact and dissemination within a three to five year timeframe